News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
701,753 Results
Type
Article (40079)
Company Profile (271)
Press Release (661403)
Multimedia
Podcasts (52)
Webinars (12)
Section
Business (205093)
Career Advice (2020)
Deals (35533)
Drug Delivery (97)
Drug Development (81240)
Employer Resources (172)
FDA (16211)
Job Trends (14914)
News (346462)
Policy (32649)
Tag
Academia (2572)
Accelerated approval (5)
Adcomms (20)
Allergies (85)
Alliances (49778)
ALS (88)
Alzheimer's disease (1384)
Antibody-drug conjugate (ADC) (127)
Approvals (16216)
Artificial intelligence (255)
Autoimmune disease (22)
Automation (16)
Bankruptcy (363)
Best Places to Work (11658)
BIOSECURE Act (20)
Biosimilars (106)
Biotechnology (190)
Bladder cancer (79)
Brain cancer (27)
Breast cancer (279)
Cancer (2265)
Cardiovascular disease (174)
Career advice (1688)
Career pathing (30)
CAR-T (153)
Cell therapy (429)
Cervical cancer (19)
Clinical research (66115)
Collaboration (841)
Company closure (1)
Compensation (533)
Complete response letters (19)
COVID-19 (2604)
CRISPR (41)
C-suite (243)
Cystic fibrosis (100)
Data (2207)
Decentralized trials (2)
Denatured (20)
Depression (43)
Diabetes (271)
Diagnostics (6390)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (120)
Drug pricing (101)
Drug shortages (25)
Duchenne muscular dystrophy (93)
Earnings (86766)
Editorial (37)
Employer branding (21)
Employer resources (146)
Events (112921)
Executive appointments (729)
FDA (17477)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (754)
Gene editing (106)
Generative AI (19)
Gene therapy (303)
GLP-1 (713)
Government (4430)
Grass and pollen (4)
Guidances (67)
Healthcare (18834)
Huntington's disease (24)
IgA nephropathy (27)
Immunology and inflammation (119)
Indications (29)
Infectious disease (2747)
Inflammatory bowel disease (141)
Inflation Reduction Act (10)
Influenza (51)
Intellectual property (96)
Interviews (311)
IPO (16541)
IRA (42)
Job creations (3665)
Job search strategy (1434)
Kidney cancer (10)
Labor market (38)
Layoffs (475)
Leadership (17)
Legal (7944)
Liver cancer (75)
Lung cancer (320)
Lymphoma (154)
Machine learning (7)
Management (58)
Manufacturing (305)
MASH (67)
Medical device (13388)
Medtech (13393)
Mergers & acquisitions (19536)
Metabolic disorders (687)
Multiple sclerosis (80)
NASH (16)
Neurodegenerative disease (89)
Neuropsychiatric disorders (27)
Neuroscience (1922)
NextGen: Class of 2025 (6548)
Non-profit (4491)
Now hiring (39)
Obesity (364)
Opinion (208)
Ovarian cancer (75)
Pain (88)
Pancreatic cancer (84)
Parkinson's disease (148)
Partnered (21)
Patents (233)
Patient recruitment (112)
Peanut (46)
People (57633)
Pharmaceutical (67)
Pharmacy benefit managers (18)
Phase I (20617)
Phase II (29120)
Phase III (21681)
Pipeline (1203)
Policy (142)
Postmarket research (2564)
Preclinical (8772)
Press Release (64)
Prostate cancer (106)
Psychedelics (30)
Radiopharmaceuticals (246)
Rare diseases (378)
Real estate (5953)
Recruiting (65)
Regulatory (22350)
Reports (46)
Research institute (2327)
Resumes & cover letters (350)
Rett syndrome (5)
RNA editing (5)
RSV (42)
Schizophrenia (69)
Series A (133)
Series B (84)
Service/supplier (13)
Sickle cell disease (52)
Special edition (14)
Spinal muscular atrophy (147)
Sponsored (29)
Startups (3629)
State (2)
Stomach cancer (13)
Supply chain (68)
Tariffs (40)
The Weekly (30)
Vaccines (691)
Venture capitalists (43)
Weight loss (235)
Women's health (35)
Worklife (16)
Date
Last 7 days (903)
Last 30 days (2490)
Last 365 days (32718)
2025 (10780)
2024 (35330)
2023 (40179)
2022 (51288)
2021 (55834)
2020 (54153)
2019 (46641)
2018 (35123)
2017 (32222)
2016 (31629)
2015 (37706)
2014 (31454)
2013 (26501)
2012 (28771)
2011 (29428)
2010 (27530)
Location
Africa (721)
Alabama (53)
Alaska (7)
Arizona (232)
Arkansas (13)
Asia (38051)
Australia (6233)
California (6158)
Canada (2018)
China (524)
Colorado (268)
Connecticut (274)
Delaware (148)
Europe (81756)
Florida (912)
Georgia (206)
Idaho (58)
Illinois (539)
India (26)
Indiana (309)
Iowa (11)
Japan (162)
Kansas (105)
Kentucky (24)
Louisiana (10)
Maine (62)
Maryland (895)
Massachusetts (4584)
Michigan (220)
Minnesota (391)
Mississippi (2)
Missouri (81)
Montana (27)
Nebraska (25)
Nevada (63)
New Hampshire (64)
New Jersey (1729)
New Mexico (28)
New York (1747)
North Carolina (968)
North Dakota (8)
Northern California (2688)
Ohio (206)
Oklahoma (14)
Oregon (35)
Pennsylvania (1379)
Puerto Rico (12)
Rhode Island (33)
South America (1099)
South Carolina (23)
South Dakota (1)
Southern California (2314)
Tennessee (101)
Texas (912)
United States (23196)
Utah (180)
Virginia (147)
Washington D.C. (63)
Washington State (555)
West Virginia (3)
Wisconsin (54)
701,753 Results for "avance biosciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Avance Biosciences™ Registers with CLIA, Expanding Clinical Trial Testing Capabilities
February 27, 2025
·
2 min read
Axogen Inc. Initiates Rolling Submission of Biologics License Application to U.S. Food and Drug Administration (FDA) for Avance Nerve Graft®
Axogen, Inc. is pleased to announce that it has initiated the rolling submission process with the U.S. Food and Drug Administration for a Biologics License Application (BLA) for licensure of Avance Nerve Graft ® on May 15, 2024.
May 16, 2024
·
7 min read
Drug Development
Oragenics Partners with Avance Clinical for Phase II Concussion Trial in Australia
Oragenics, Inc., a pioneer in developing innovative intranasal pharmaceuticals for neurological disorders, announced a partnership with Avance Clinical, a leading Contract Research Organization, to conduct a Phase II clinical trial in Australia.
May 7, 2024
·
4 min read
Press Releases
Parse Biosciences Partners with Japanese Distributor, SCRUM Inc.
April 2, 2025
·
2 min read
Press Releases
Ensysce Biosciences, Inc. Announces Exercise of Warrants for $2.2 Million Gross Proceeds
April 23, 2025
·
4 min read
Press Releases
Xenetic Biosciences, Inc. Releases Virtual Investor “What This Means” Segment
April 10, 2025
·
5 min read
Avance Clinical Expands Specialist CNS, Cardiometabolic, and Rare Diseases CRO Services in Europe with Julius Clinical
Avance Clinical, the award-winning Australian and North American market-leading CRO for biotechs, has signed a Memorandum of Understanding (MOU) with Julius Clinical, a leading CNS
June 3, 2024
·
3 min read
Press Releases
Forte Biosciences, Inc. Announces Results and Provides Clinical Update
March 31, 2025
·
7 min read
Press Releases
Ensysce Biosciences, Inc. Announces Closing of Exercise of Warrants for $2.2 Million Gross Proceeds
April 25, 2025
·
4 min read
Press Releases
Avance Clinical Leads as the CRO of Choice for Early Phase Clinical Trials in Australia – Announced at Biotech Showcase 2025
January 14, 2025
·
1 min read
1 of 70,176
Next
